[{"NetIncomeLoss_1_Q3_USD":-119803000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":142276000.0,"DepreciationAndAmortization_3_Q3_USD":9603000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q3_USD":278700000.0,"UndistributedEarningsLossAvailableToCommonShareholdersDiluted_1_Q3_USD":0.0,"UndistributedEarningsLossAvailableToCommonShareholdersDiluted_3_Q3_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q3_USD":-192000.0,"NetIncomeLossAttributableToNoncontrollingInterest_3_Q3_USD":-368000.0,"MarketableSecuritiesCurrent_0_Q3_USD":122934000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"IncreaseDecreaseInReceivables_3_Q3_USD":697000.0,"OperatingLeaseLiability_0_Q3_USD":91574000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_3_Q3_USD":9.68,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_0_Q3_shares":3487870.0,"GainLossOnInvestments_3_Q3_USD":17047000.0,"Liabilities_0_Q3_USD":621463000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":1421966000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":79930000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":39735000.0,"OtherAssetsNoncurrent_0_Q3_USD":4664000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":48489000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-3549000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q3_USD":4048000.0,"CommitmentsAndContingencies_0_Q3_USD":null,"LossContingencyLossInPeriod_3_Q3_USD":100000.0,"TreasuryStockShares_0_Q3_shares":7568182.0,"DerivativeGainLossOnDerivativeNet_1_Q3_USD":-1800000.0,"DerivativeGainLossOnDerivativeNet_3_Q3_USD":100000.0,"LongTermDebtCurrent_0_Q3_USD":27486000.0,"OperatingLeaseExpense_1_Q3_USD":3725000.0,"OperatingLeaseExpense_3_Q3_USD":8623000.0,"AssetsCurrent_0_Q3_USD":200720000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":10520000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_3_Q3_shares":6707485.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":41918000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":82052000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q3_USD":47535000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":1155000.0,"InterestPaidNet_3_Q3_USD":86000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":23575000.0,"PaidInKindInterest_3_Q3_USD":5899000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":-192000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":-368000.0,"RepaymentsOfLongTermDebt_3_Q3_USD":72711000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-119781000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-283273000.0,"OtherAssetsCurrent_0_Q3_USD":3974000.0,"GainsLossesOnExtinguishmentOfDebt_3_Q3_USD":-6695000.0,"PrepaidExpenseCurrent_0_Q3_USD":12196000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":299276000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":290029000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_3_Q3_shares":3829618.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":428000.0,"AdjustmentForAmortization_1_Q3_USD":1000000.0,"AdjustmentForAmortization_3_Q3_USD":3105000.0,"MinorityInterest_0_Q3_USD":-174000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q3_USD":4140000.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q3_shares":0.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_3_Q3_shares":0.0,"EarningsPerShareBasic_1_Q3_USD":-0.4,"EarningsPerShareBasic_3_Q3_USD":-0.98,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q3_USD":18470000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":184541000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q3_USD":6.24,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":2567000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":417000.0,"GainsLossesOnExtinguishmentOfDebt_1_Q3_USD":0.0,"AccountsReceivableNetCurrent_0_Q3_USD":16454000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":-461000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":386000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_3_Q3_USD":124113000.0,"RestrictedCash_0_Q3_USD":0.0,"NonoperatingGainsLosses_1_Q3_USD":97000.0,"NonoperatingGainsLosses_3_Q3_USD":53000.0,"CostsAndExpenses_1_Q3_USD":113449000.0,"CostsAndExpenses_3_Q3_USD":326670000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":110475000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":49448000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":147787000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":23608000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_3_Q3_USD":-4941000.0,"EffectiveIncomeTaxRateContinuingOperations_3_Q3_pure":0.002,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":-300000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":-841000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_3_Q3_USD":9.96,"GoodwillPeriodIncreaseDecrease_3_Q3_USD":9300000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q3_USD":21103000.0,"CommonStockValue_0_Q3_USD":31000.0,"NumberOfReportableSegments_3_Q3_Segment":2.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_0_Q3_USD":9.5,"EffectiveIncomeTaxRateContinuingOperations_1_Q3_pure":0.003,"TreasuryStockValue_0_Q3_USD":49464000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":10534000.0,"IncomeTaxesPaidNet_3_Q3_USD":1200000.0,"AccountsPayableCurrent_0_Q3_USD":27839000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_3_Q3_USD":-17157000.0,"LiabilitiesCurrent_0_Q3_USD":175184000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":10355000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q3_USD":65682000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":299276000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":290029000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-209684000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q3_USD":22000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_3_Q3_USD":635000.0,"ProceedsFromShortTermDebt_3_Q3_USD":35053000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-119773000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-284460000.0,"Goodwill_0_Q3_USD":52892000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":22000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":635000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q3_USD":3870000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":164000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-277000.0,"InterestExpense_3_Q3_USD":7282000.0,"InterestExpense_1_Q3_USD":2900000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":39735000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":13255000.0,"NetIncomeLoss_3_Q3_USD":-283908000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":45750000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q3_USD":121504000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":1162000.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q3_USD":5083000.0,"OperatingLeasePayments_1_Q3_USD":3208000.0,"OperatingLeasePayments_3_Q3_USD":8081000.0,"NumberOfOperatingSegments_3_Q3_Segment":2.0,"MarketableSecuritiesGainLoss_1_Q3_USD":-13483000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":42310000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":131327000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":39735000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q3_USD":-119803000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_3_Q3_USD":-283908000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.128,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_3_Q3_pure":0.21,"IntangibleAssetsNetExcludingGoodwill_0_Q3_USD":320970000.0,"LongTermDebtNoncurrent_0_Q3_USD":83495000.0,"DeferredIncomeTaxesAndTaxCredits_3_Q3_USD":-1834000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":869676.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-119973000.0,"MarketableSecuritiesGainLoss_3_Q3_USD":17047000.0,"EarningsPerShareDiluted_1_Q3_USD":-0.4,"PreferredStockValue_0_Q3_USD":null,"FiniteLivedIntangibleAssetsGross_0_Q3_USD":339440000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3_Q3_USD":9.34,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":2284000.0,"InventoryNet_0_Q3_USD":5427000.0,"OperatingIncomeLoss_1_Q3_USD":-101387000.0,"OperatingIncomeLoss_3_Q3_USD":-286842000.0,"CommonStockSharesAuthorized_0_Q3_shares":750000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":6058000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":34734000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":92967000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"StockIssuedDuringPeriodValueAcquisitions_1_Q3_USD":812000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_3_Q3_USD":5.33,"OperatingLeaseRightOfUseAsset_0_Q3_USD":76674000.0,"ShareBasedCompensation_3_Q3_USD":67509000.0,"Assets_0_Q3_USD":752790000.0,"CommonStockSharesIssued_0_Q3_shares":303466554.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_3_Q3_USD":3.91,"LiabilitiesAndStockholdersEquity_0_Q3_USD":752790000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":16674000.0,"PreferredStockSharesAuthorized_0_Q3_shares":100000000.0,"EarningsPerShareDiluted_3_Q3_USD":-0.98,"CommonStockSharesOutstanding_0_Q3_shares":303466554.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-1242187000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q3_shares":23406814.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":12062000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":39828000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":6662000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":119206000.0,"StockholdersEquity_0_Q3_USD":131501000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q3_USD":3845000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1761000.0,"ProfitLoss_3_Q3_USD":-284276000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q3_USD":39967000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":40141000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":35589000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q3_USD":1035000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":11644000.0,"DerivativeLiabilitiesNoncurrent_0_Q3_USD":35300000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3_Q3_shares":1193915.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_3_Q3_shares":209208.0,"ProfitLoss_1_Q3_USD":-119995000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-283641000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20211105"}]